|4Mar 3, 5:07 PM ET

Atkisson Erik 4

4 · Rain Oncology Inc. · Filed Mar 3, 2023

Insider Transaction Report

Form 4
Period: 2023-03-02
Atkisson Erik
General Counsel and CCO
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-03-02+120,000120,000 total
    Exercise: $9.34Exp: 2033-03-02Common Stock (120,000 underlying)
Footnotes (1)
  • [F1]This option represents a right to purchase a total of 120,000 shares of the Issuer's common stock, one quarter of which will vest on February 21, 2024, with the remaining three quarters vesting in equal monthly installments through February 21, 2027, subject to the Reporting Person's continued service to the Issuer.

Documents

1 file
  • 4
    tm238527-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT